Dashboard
Manage Tickers

IGMSIGM Biosciences, Inc.

Nasdaq igmbio.com


$ 10.09 $ 0.78 (8.35 %)    

Thursday, 09-May-2024 15:59:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 10.12
$ 8.98
$ 10.09 x 100
$ 0.00 x 0
$ 8.77 - $ 10.24
$ 3.81 - $ 17.70
231,609
na
608.36M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-07-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-29-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-26-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wedbush-reiterates-outperform-on-igm-biosciences-maintains-20-price-target
Wedbush Reiterates Outperform on IGM Biosc...
05/09/2024 12:49:01

Wedbush analyst Robert Driscoll reiterates IGM Biosciences (NASDAQ:IGMS) with a Outperform and maintains $20 price target.

igm-biosciences-q1-eps-083-inline-sales-49700k-miss-76000k-estimate
IGM Biosciences Q1 EPS $(0.83), Inline, Sa...
05/08/2024 22:10:57

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.83) per share which met the analyst consensus estimate. This is ...

what-5-analyst-ratings-have-to-say-about-igm-biosciences
What 5 Analyst Ratings Have To Say About I...
04/18/2024 18:02:28

hc-wainwright--co-reiterates-neutral-on-igm-biosciences-maintains-12-price-target
HC Wainwright & Co. Reiterates Neutral on ...
04/18/2024 10:33:45

HC Wainwright & Co. analyst Robert Burns reiterates IGM Biosciences (NASDAQ:IGMS) with a Neutral and maintains $12 price...

igm-biosciences-announces-worldwide-collaboration-agreement-with-sanofi-to-create-and-develop-igm-agonist-antibodies-will-focus-exclusively-on-immunologyinflammation-targets
IGM Biosciences Announces Worldwide Collab...
04/17/2024 12:33:59

where-igm-biosciences-stands-with-analysts
Where IGM Biosciences Stands With Analysts
03/08/2024 20:01:10

rbc-capital-reiterates-outperform-on-igm-biosciences-maintains-21-price-target
RBC Capital Reiterates Outperform on IGM B...
03/08/2024 16:20:41

RBC Capital analyst Brian Abrahams reiterates IGM Biosciences (NASDAQ:IGMS) with a Outperform and maintains $21 price target.

wedbush-reiterates-outperform-on-igm-biosciences-maintains-20-price-target
Wedbush Reiterates Outperform on IGM Biosc...
03/08/2024 15:11:53

Wedbush analyst Robert Driscoll reiterates IGM Biosciences (NASDAQ:IGMS) with a Outperform and maintains $20 price target.

igm-biosciences-q4-eps-101-beats-103-estimate-sales-65100k-miss-70000k-estimate
IGM Biosciences Q4 EPS $(1.01) Beats $(1.0...
03/07/2024 21:41:42

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(1.01) per share which beat the analyst consensus estimate of $(1.0...

why-big-lots-shares-are-trading-lower-by-around-31-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Big Lots Shares Are Trading Lower By A...
02/12/2024 18:07:28

Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarte...

cymabay-therapeutics-contextlogic-snap-and-other-big-stocks-moving-higher-on-monday
CymaBay Therapeutics, ContextLogic, Snap A...
02/12/2024 15:22:57

U.S. stocks were mixed, with the Nasdaq Composite trading almost flat on Monday. Shares of CymaBay Therapeutics, Inc. (NASDAQ...

rbc-capitals-rating-upgrade-propels-igm-biosciences-into-immunology-limelight
RBC Capital's Rating Upgrade Propels IGM B...
02/09/2024 19:16:35

IGM Biosciences' strategic shift to immunology with promising bispecific drug, imvotamab. RBC Capital upgraded stock to Out...

why-take-two-interactive-software-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Take-Two Interactive Software Shares A...
02/09/2024 18:18:14

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter res...

rbc-capital-upgrades-igm-biosciences-to-outperform-raises-price-target-to-21
RBC Capital Upgrades IGM Biosciences to Ou...
02/09/2024 15:33:50

RBC Capital analyst Brian Abrahams upgrades IGM Biosciences (NASDAQ:IGMS) from Sector Perform to Outperform and raises the p...

sps-commerce-posts-upbeat-results-joins-masonite-international-impinj-and-other-big-stocks-moving-higher-on-friday
SPS Commerce Posts Upbeat Results, Joins M...
02/09/2024 15:31:44

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ...

morgan-stanley-reports-q4-results-joins-boeing-alcoa-and-other-big-stocks-moving-lower-on-tuesday
Morgan Stanley Reports Q4 Results, Joins B...
01/16/2024 18:17:00

U.S. stocks traded lower, with the Dow Jones index falling more than 250 points on Tuesday.

acuity-brands-posts-upbeat-earnings-joins-accolade-urban-outfitters-and-other-big-stocks-moving-higher-on-tuesday
Acuity Brands Posts Upbeat Earnings, Joins...
01/09/2024 15:59:03

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.

zimvie-agrees-to-sell-its-spine-business-joins-united-states-steel-pgt-innovations-and-other-big-stocks-moving-higher-on-monday
ZimVie Agrees To Sell Its Spine Business, ...
12/18/2023 15:57:14

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 30 points on Monday.

b-of-a-securities-downgrades-igm-biosciences-to-neutral-announces-8-price-target
B of A Securities Downgrades IGM Bioscienc...
12/15/2023 13:39:20

B of A Securities analyst Geoff Meacham downgrades IGM Biosciences (NASDAQ:IGMS) from Buy to Neutral and announces $8 price ...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
12/08/2023 21:30:48

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION